1. Home
  2. VERA vs SEMR Comparison

VERA vs SEMR Comparison

Compare VERA & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • SEMR
  • Stock Information
  • Founded
  • VERA 2016
  • SEMR 2008
  • Country
  • VERA United States
  • SEMR United States
  • Employees
  • VERA N/A
  • SEMR N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • SEMR EDP Services
  • Sector
  • VERA Health Care
  • SEMR Technology
  • Exchange
  • VERA Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • VERA 2.5B
  • SEMR 1.9B
  • IPO Year
  • VERA 2021
  • SEMR 2021
  • Fundamental
  • Price
  • VERA $42.01
  • SEMR $13.28
  • Analyst Decision
  • VERA Strong Buy
  • SEMR Buy
  • Analyst Count
  • VERA 9
  • SEMR 8
  • Target Price
  • VERA $53.56
  • SEMR $15.38
  • AVG Volume (30 Days)
  • VERA 683.6K
  • SEMR 322.1K
  • Earning Date
  • VERA 11-07-2024
  • SEMR 11-07-2024
  • Dividend Yield
  • VERA N/A
  • SEMR N/A
  • EPS Growth
  • VERA N/A
  • SEMR N/A
  • EPS
  • VERA N/A
  • SEMR 0.10
  • Revenue
  • VERA N/A
  • SEMR $338,875,000.00
  • Revenue This Year
  • VERA N/A
  • SEMR $24.08
  • Revenue Next Year
  • VERA N/A
  • SEMR $19.38
  • P/E Ratio
  • VERA N/A
  • SEMR $127.37
  • Revenue Growth
  • VERA N/A
  • SEMR 20.97
  • 52 Week Low
  • VERA $9.68
  • SEMR $7.36
  • 52 Week High
  • VERA $50.78
  • SEMR $16.42
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • SEMR 44.11
  • Support Level
  • VERA $39.22
  • SEMR $12.61
  • Resistance Level
  • VERA $50.00
  • SEMR $13.20
  • Average True Range (ATR)
  • VERA 2.41
  • SEMR 0.34
  • MACD
  • VERA 0.24
  • SEMR -0.02
  • Stochastic Oscillator
  • VERA 28.53
  • SEMR 40.22

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

Share on Social Networks: